Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Penile Neoplasms × dacomitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Carcinoma, Squamous Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Brain Neoplasms 3 Recurrence 2 Neoplasm Metastasis 2 NSCLC 2 Glioblastoma 2 Thrombocytosis 1 Rare Tumor 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pembrolizumab 4 Paclitaxel 4 Ifosfamide 4 Cisplatin 4 Nivolumab 3 avelumab 2 Magnetic Resonance Spectroscopy 2 vinflunine 1 toripalimab 1 niraparib 1 nimotuzumab 1 enfortumab vedotin 1 dostarlimab 1 dacomitinib 1 cemiplimab 1 cabazitaxel 1 aldesleukin 1 Vorinostat 1 Ultrasonography 1 Surveys and Questionnaires 1 Sildenafil Citrate 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Psychiatric Nursing 1 Physical Therapy Modalities 1 Palliative Care 1 Magnetic Resonance Imaging 1 Isotretinoin 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01728233 2021-05-14

HER-Uro01

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed

Carcinoma, Squamous Cell, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡